BiotechTube
Home/Lysoway Therapeutics/Yongchang Qiu, PhD
YQ

Yongchang Qiu, PhD

Founder and CEO

Lysoway Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesLysosomal Storage Disorders

Lysoway Therapeutics Pipeline

DrugIndicationPhase
TRPML1 Agonist ProgramAlzheimer's Disease, Parkinson's Disease, Lysosomal Storage DisordersPre-clinical
TMEM175 Agonist ProgramAlzheimer's Disease, Parkinson's Disease, Lysosomal Storage DisordersPre-clinical

Leadership Team at Lysoway Therapeutics

XY
Xiang Yang Yu, PhD
SVP, Drug Development
VC
Valerie Cullen, PhD
SVP, Head of Research and Translational Sciences
JY
Junsheng Yang, PhD
Senior Director, Discovery Research
View full Lysoway Therapeutics profile